Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon Hill

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Reproductive Toxicology (Elmsford, N.Y.)|February 27, 2022
The grouping of chemicals with effects on reproduction and development for the purpose of cumulative risk assessment in EuropeMary Moxon, Stephanie Melching-Kollmuss, Giovanna Semino-Beninel, et al.
International Urogynecology Journal and Pelvic Floor Dysfunction|April 24, 2009
Validation of the pelvic organ prolapse quantification (POP-Q) system in left lateral positionG Alessandro Digesu, Stavros Athanasiou, Linda Cardozo, et al.
Neurourology and Urodynamics|April 14, 2017
Tolterodine ER reduced increased bladder wall thickness in women with overactive bladder. A randomized, placebo-controlled, double-blind, parallel group studyRhiannon Bray, Rufus Cartwright, Linda Cardozo, et al.
International Urogynecology Journal and Pelvic Floor Dysfunction|October 31, 2007
How accurate is symptomatic and clinical evaluation of prolapse prior to surgical repair?Abdalla Fayyad, Simon Hill, Vinita Gurung, et al.
Chemical Research in Toxicology|March 23, 2011
Letter to the editor regarding the article by Paganelli et AlDavid Saltmiras, James S Bus, Terri Spanogle, et al.
Urology|August 11, 2004
Treatment of urge-predominant mixed urinary incontinence with tolterodine extended release: a randomized, placebo-controlled trialVik Khullar, Simon Hill, Karl-Ulrich Laval, et al.
International Urogynecology Journal and Pelvic Floor Dysfunction|October 25, 2006
Current and future trends in the management of overactive bladderAdrian Wagg, Amitabha Majumdar, Philip Toozs-Hobson, et al.
Journal of Affective Disorders|October 30, 2024
Omnivore, vegan and vegetarian diet quality associations with depressive symptoms: A comparative cross-sectional analysis of the Australian Longitudinal Study on Women's HealthMegan Lee, Lauren Ball, Simon Hill, et al.
Current Medical Research and Opinion|September 26, 2007
Long-term darifenacin treatment for overactive bladder in patients aged 65 years and older: analysis of results from a 2-year, open-label extension studySimon Hill, Mostafa Elhilali, Richard J Millard, et al.
European Urology|August 25, 2005
Stress incontinence injection therapy: what is best for our patients?Christopher R Chapple, Alan J Wein, Linda Brubaker, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Reproductive Toxicology (Elmsford, N.Y.)|February 27, 2022
The grouping of chemicals with effects on reproduction and development for the purpose of cumulative risk assessment in EuropeMary Moxon, Stephanie Melching-Kollmuss, Giovanna Semino-Beninel, et al.
International Urogynecology Journal and Pelvic Floor Dysfunction|April 24, 2009
Validation of the pelvic organ prolapse quantification (POP-Q) system in left lateral positionG Alessandro Digesu, Stavros Athanasiou, Linda Cardozo, et al.
Neurourology and Urodynamics|April 14, 2017
Tolterodine ER reduced increased bladder wall thickness in women with overactive bladder. A randomized, placebo-controlled, double-blind, parallel group studyRhiannon Bray, Rufus Cartwright, Linda Cardozo, et al.
International Urogynecology Journal and Pelvic Floor Dysfunction|October 31, 2007
How accurate is symptomatic and clinical evaluation of prolapse prior to surgical repair?Abdalla Fayyad, Simon Hill, Vinita Gurung, et al.
Chemical Research in Toxicology|March 23, 2011
Letter to the editor regarding the article by Paganelli et AlDavid Saltmiras, James S Bus, Terri Spanogle, et al.
Urology|August 11, 2004
Treatment of urge-predominant mixed urinary incontinence with tolterodine extended release: a randomized, placebo-controlled trialVik Khullar, Simon Hill, Karl-Ulrich Laval, et al.
International Urogynecology Journal and Pelvic Floor Dysfunction|October 25, 2006
Current and future trends in the management of overactive bladderAdrian Wagg, Amitabha Majumdar, Philip Toozs-Hobson, et al.
Journal of Affective Disorders|October 30, 2024
Omnivore, vegan and vegetarian diet quality associations with depressive symptoms: A comparative cross-sectional analysis of the Australian Longitudinal Study on Women's HealthMegan Lee, Lauren Ball, Simon Hill, et al.
Current Medical Research and Opinion|September 26, 2007
Long-term darifenacin treatment for overactive bladder in patients aged 65 years and older: analysis of results from a 2-year, open-label extension studySimon Hill, Mostafa Elhilali, Richard J Millard, et al.
European Urology|August 25, 2005
Stress incontinence injection therapy: what is best for our patients?Christopher R Chapple, Alan J Wein, Linda Brubaker, et al.
Pageof 4